Descending Aorta Blood Flow to Guide Fluid Therapy During Surgery
NCT ID: NCT05227729
Last Updated: 2024-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2022-10-18
2024-01-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vascular Function on the First Day After Cardiac Surgery
NCT02001090
Traditional Versus ScvO2 Guided Perioperative Fluid Therapy
NCT00468793
The Relationship Between Cardiac Output and Microvascular Visceral Blood Flow
NCT02167178
Circulatory Oscillations in Post Cardiac Surgery Patients
NCT02765607
Intermittent Cold Blood vs Crystalloid Cardioplegia in Aortic Valve Surgery
NCT00257777
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fluid challenges are typically given when stroke volume is reduced by 10-15%, which is considered a significant reduction. This is however dependent on the precision of the measurements, which is estimated during hemodynamic stability. During surgery, on the other hand, the variability may be larger, leading to erroneously concluding that stroke volume is reduced due to volume loss, when in fact this may be due to other stimuli related to surgery (mechanical, e.g. compression of large veins or the thoracic cavity, or stimuli affecting the autonomic nervous system, e.g. pain). The proportion of potentially falsely measured reduction may be calculated by performing repeated measurements during ongoing surgery. Thus, an other aim with this study is to explore the variability of measurements of stroke volume during surgery.
Study design: Clinical observational study.
Data collection: 30 patients scheduled to undergo laparoscopic or open abdominal surgical procedures (gastrointestinal or gynecological) of at least 1.5 hrs estimated duration. The patients should be of American Society of Anesthesiologists physical status 1-3 and have no contraindications to the use of oesophageal ultrasound. Hemodynamic data will be downloaded to a PC continuously from the clinical monitoring equipment (Philips Intellivue) using the VSCapture software (https://github.com/xeonfusion/VSCaptureMP) in VisualStudio (Microsoft). "Landmarks" in the procedure (e.g. surgical incision, manipulation in the surgical field and hemorrhage) will be recorded manually to relate the hemodynamic data to the different steps in the procedure. Blood flow velocity in the descending aorta will be measured using ultrasound machines in ordinary clinical use (GE Venue R 2.5; GE Healthcare). The Doppler recordings will be analyzed using commercially available software (EchoPAC; General Electric) after blinding.
Data analyzes:
* Considerations regarding sample size for agreement analyzes: The investigators will focus on within-subject variability, and the main outcome will be the corresponding within-subject limits of agreement. If both methods have a precision of 2.9%, limits of agreement will be 8.3%. Given 18 measurements per subject (one measurement every 5 min over 1.5 hrs), 25 subjects will give an 80% power for an upper confidence interval of the limits of agreement of 18%. By including 30 patients, the investigators allow for some unsuccessful measurements due to e.g. poor echogenicity.
* Considerations regarding sample size for variability analyzes: Given that the SD of oesophageal Doppler is 2.9%, the precision is 2.9%×1.96=5.7%. The probability of each evaluation of showing a false reduction is 0.8%. If surgery lasts 1.5 hrs with one evaluation every 5 min, the probability of at least one false reduction is 12%. If the precision is reduced with a doubled SD, the probability of at least one false reduction is 88%. Assuming a true SD of 2.9%; studying 25 subjects gives a power of 0.8 to detect a SD \<3.0%.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing abdominal surgery
Inclusion criteria: \> 18 years old, American Society of Anesthesiologists physical status 1-3, abdominal surgery of \> 1,5 hrs estimated duration, no contraindications to the use of oesophageal ultrasound.
Measurement of blood flow in descending aorta by suprasternal ultrasound Doppler technique
While study subjects are in general anesthesia the investigator will perform repeated measurements every 5 min.
Measurement of blood flow in descending aorta by transoesophageal ultrasound Doppler technique
While study subjects are in general anesthesia the investigator will perform repeated measurements every 5 min.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measurement of blood flow in descending aorta by suprasternal ultrasound Doppler technique
While study subjects are in general anesthesia the investigator will perform repeated measurements every 5 min.
Measurement of blood flow in descending aorta by transoesophageal ultrasound Doppler technique
While study subjects are in general anesthesia the investigator will perform repeated measurements every 5 min.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patients should be of American Society of Anesthesiologists physical status 1-3
Exclusion Criteria
* Former surgery in larynx, oesophagus or stomach
* Thoracic aortic aneurysm.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
University of Oslo
OTHER
Sykehuset Telemark
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Torkjell Nostdahl
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Torkjell Nøstdahl, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Telemark Hospital Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Telemark Hospital Trust
Skien, Vestfold Og Telemark, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
264472
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.